Conditions: Neoplasms, Prostate
Keywords: Dutasteride Prostate Cancer Expectant management REDEEM
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 302
Healthy volunteers: no

Brief summary:
The purpose of this study is to examine the effect of dutasteride on the inhibition of low-risk, localized prostate cancer progression in men who would otherwise receive no active therapy (expectant management).

Detailed description:

Arms:
arm 1: Dutasteride 0.5mg arm 2: Matching placebo

Interventions: intervention 1: Dutasteride intervention 2: Matching placebo
Intervention descriptions: intervention 1: Dutasteride 0.5mg intervention 2: Matching placebo

Protocol document: